WHO Unveils New Framework Linking Climate Change and Tuberculosis Control
WHO Launches Comprehensive Framework Addressing the Intersection of Climate Change and Tuberculosis In a decisive move to confront two of the world’s most pressing public health challenges, the World Health…
78th World Health Assembly Concludes with Historic Milestones
Global Unity, Historic Milestones: 78th World Health Assembly Concludes with Ambitious Health Agenda The Seventy-eighth World Health Assembly (WHA78), the flagship decision-making forum of the World Health Organization (WHO), drew…
Elanco Appoints Bob VanHimbergen to CFO Role
Elanco Names Robert VanHimbergen as New CFO, Succeeding Todd Young in Strategic Leadership Transition Elanco Animal Health Incorporated has officially announced the appointment of Robert (Bob) VanHimbergen as Executive Vice…
EU Approves Subcutaneous Opdivo with Halozyme’s ENHANZE for Multiple Tumors
Halozyme and Bristol Myers Squibb Secure European Commission Approval for Subcutaneous Opdivo Co-Formulated with ENHANZE in Multiple Solid Tumors Halozyme Therapeutics celebrates a significant regulatory milestone as Bristol Myers Squibb…
BeOne Medicines Launches in Switzerland, Begins New Global Oncology Chapter
BeOne Medicines Officially Launches Following Redomiciliation to Switzerland, Ushering in a New Era of Global Oncology Leadership BeOne Medicines Ltd. formerly known as BeiGene, Ltd., has officially entered a transformative…
BioNTech to Showcase Oncology Pipeline Progress at ASCO 2025
BioNTech to Showcase Broad Advancements in Oncology Pipeline at 2025 ASCO Annual Meeting BioNTech ,a global biotechnology company known for pioneering mRNA-based technologies, announced that it will present significant clinical…
Pharma Boosts R&D Spending Despite 2024 Headwinds
Pharma Doubles Down on R&D Amid Global Headwinds, Eyes Nearly $340 Billion in Investment by 2030 Despite formidable political and economic challenges ranging from inflation and rising operational costs to…
AskBio Publishes Full Phase 1b Results of AB-1005 Gene Therapy for Parkinson’s Disease
AskBio Publishes Complete Phase 1b Trial Results of AB-1005 Gene Therapy for Parkinson’s Disease in Leading Neurology Journal Asklepios BioPharmaceutical, Inc. (AskBio), a pioneering gene therapy company that operates as…
Biogen and City Therapeutics Partner on Novel RNAi Therapy Research
Biogen and City Therapeutics Forge Strategic Partnership to Pioneer Next-Generation RNAi-Based Therapies Targeting Central Nervous System Diseases Biogen,a global leader in neuroscience and neurodegenerative disease research, and City Therapeutics, Inc.,…
Takeda and Nature Open 2026 Innovators in Science Award Applications
Takeda and Nature Open Applications for 2026 Innovators in Science Award to Celebrate Emerging Scientific Talent Takeda Pharmaceutical Company Limited has officially opened the application window for its prestigious Innovators…
Novartis Launches Tender Offer to Acquire Regulus Therapeutics
Novartis Launches Tender Offer to Acquire Regulus Therapeutics in $7 Per Share Deal, with Potential Bonus Payout Linked to Regulatory Milestone In a strategic move that underscores its continued investment…
CHMP Recommends EU Approval of Imfinzi as First Perioperative Immunotherapy for Bladder Cancer
AstraZeneca’s Imfinzi Gains CHMP Backing as First Perioperative Immunotherapy for Muscle-Invasive Bladder Cancer in the EU AstraZeneca has announced a significant regulatory milestone for its cancer immunotherapy, Imfinzi (durvalumab), with…